Volume 10, Issue 1, Pages (July 2009)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 6, Pages (December 2011)
Advertisements

Volume 10, Issue 7, Pages (February 2015)
Volume 9, Issue 3, Pages (March 2009)
Volume 17, Issue 3, Pages (March 2013)
Volume 15, Issue 1, Pages (January 2012)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 15, Issue 4, Pages (April 2012)
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 8, Issue 5, Pages (November 2008)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 6, Issue 3, Pages (September 2007)
Volume 11, Issue 4, Pages (April 2010)
Volume 12, Issue 4, Pages (October 2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 2, Issue 2, Pages (August 2005)
Volume 24, Issue 4, Pages (October 2016)
Volume 15, Issue 5, Pages (May 2012)
Transgenic Mouse Technology in Skin Biology: Generation of Complete or Tissue- Specific Knockout Mice  Lukas Scharfenberger, Tina Hennerici, Gábor Király,
Volume 23, Issue 4, Pages (April 2016)
Volume 15, Issue 1, Pages (January 2012)
Volume 25, Issue 2, Pages (February 2017)
Volume 8, Issue 5, Pages (November 2010)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Volume 7, Issue 4, Pages (May 2014)
Volume 12, Issue 6, Pages (December 2010)
Volume 14, Issue 2, Pages (August 2011)
Volume 9, Issue 3, Pages (March 2009)
Volume 2, Issue 5, Pages (November 2005)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 23, Issue 6, Pages (June 2016)
Volume 137, Issue 4, Pages (May 2009)
Volume 16, Issue 4, Pages (October 2012)
Volume 9, Issue 5, Pages (May 2009)
Volume 6, Issue 4, Pages (October 2007)
Volume 10, Issue 5, Pages (November 2009)
Volume 17, Issue 2, Pages (October 2016)
Volume 8, Issue 2, Pages (August 2008)
Volume 14, Issue 1, Pages (July 2011)
Volume 5, Issue 5, Pages (May 2007)
Volume 1, Issue 4, Pages (April 2005)
Volume 9, Issue 6, Pages (December 2014)
Volume 18, Issue 1, Pages (July 2013)
Volume 6, Issue 1, Pages (July 2007)
Joseph T. Rodgers, Wilhelm Haas, Steven P. Gygi, Pere Puigserver 
Volume 14, Issue 4, Pages (October 2011)
Volume 16, Issue 2, Pages (August 2012)
Volume 11, Issue 4, Pages (April 2010)
Volume 21, Issue 3, Pages (March 2015)
Prevention of Steatosis by Hepatic JNK1
Volume 15, Issue 6, Pages (June 2012)
Volume 10, Issue 7, Pages (February 2015)
Volume 9, Issue 5, Pages (May 2009)
Volume 12, Issue 3, Pages (September 2010)
Volume 8, Issue 1, Pages (July 2008)
Volume 21, Issue 2, Pages (February 2015)
Volume 3, Issue 5, Pages (May 2006)
Hfe Acts in Hepatocytes to Prevent Hemochromatosis
Volume 43, Issue 1, Pages (July 2011)
Xiaoyue Pan, Yuxia Zhang, Li Wang, M. Mahmood Hussain  Cell Metabolism 
Volume 12, Issue 3, Pages (September 2010)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 6, Issue 4, Pages (October 2007)
Volume 5, Issue 5, Pages (May 2007)
Volume 4, Issue 5, Pages (November 2006)
Volume 18, Issue 1, Pages (July 2013)
Volume 1, Issue 5, Pages (May 2005)
Volume 26, Issue 8, Pages e7 (February 2019)
Presentation transcript:

Volume 10, Issue 1, Pages 55-62 (July 2009) CRTC2 (TORC2) Contributes to the Transcriptional Response to Fasting in the Liver but Is Not Required for the Maintenance of Glucose Homeostasis  John Le Lay, Geetu Tuteja, Peter White, Ravindra Dhir, Rexford Ahima, Klaus H. Kaestner  Cell Metabolism  Volume 10, Issue 1, Pages 55-62 (July 2009) DOI: 10.1016/j.cmet.2009.06.006 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Derivation of the CRTC2−/− Mouse (A) loxP sites were positioned to flank exon 4 and exon 11 of the Crtc2 gene as well as a Neomycin (Neo) selection cassette. Mice harboring the CRTC2 loxP allele were crossed to EIIa-Cre transgenic mice, resulting in a null allele lacking the loxP-flanked exons and the Neomycin selection cassette. (B) Western blot analysis of whole-cell liver lysates taken from mice homozygous for the null allele (−/−) or littermate controls (+/+). Livers were dissected from mice fed ad libitum or fasted for the amount of time indicated. (C) Quantitative RT-PCR to measure relative CRTC1 mRNA levels in the liver of control (+/+) and CRTC2−/− (−/−) mice fasted for the indicated amount of time or allowed to feed ad libitum (fed). Transcript levels in control mice were assigned an arbitrary value of 1.0 for comparison. n = 5 for each group. Values are presented as average ± SD. Cell Metabolism 2009 10, 55-62DOI: (10.1016/j.cmet.2009.06.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 CRTC2 Knockout Mice Maintain Normal Fed and Fasting Glycemia (A and B) Blood glucose levels of control (+/+) and CRTC2−/− (−/−) mice during the course of a 24 hr fast. n = 8–12 for each group. (C) Blood glucose levels of control (+/+) and CRTC2−/− (−/−) mice after overnight fasting (0 min) and following injection of a pyruvate bolus at the times indicated. n = 6 for each group. (D) Hepatic glucose production (HGP) was measured before (Basal HGP) and during a hyperinsulinemic-hypoglycemic clamp. Glucose infusion rate (GIR) and glucose disposal (Rd) were also measured during the clamp. n = 4 for each group. Values are presented as average ± SD. Cell Metabolism 2009 10, 55-62DOI: (10.1016/j.cmet.2009.06.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 The Transcriptional Response to Fasting Is Blunted in CRTC2−/− Hepatocytes (A) Quantitative RT-PCR to measure relative G6Pase, PEPCK, and PGC-1α mRNA levels in the liver of control (+/+) and CRTC2−/− (−/−) mice fasted for the indicated amount of time, refed following an overnight fast (refed), or allowed to feed ad libitum (fed). (B) Quantitative RT-PCR to measure relative G6Pase, PEPCK, and PGC-1α mRNA levels in primary hepatocytes isolated from control (+/+) and CRTC2−/− (−/−) mice 2 hr after treatment with 50 nM glucagon. Transcript levels in control cells were assigned an arbitrary value of 1.0 for comparison. (C) Glucose levels were measured in the culture medium of primary hepatocytes isolated from control (+/+) and CRTC2−/− (−/−) mice 5 hr after treatment with or without 50 nM glucagon. n = 6–10 for each group. (D and E) Glycogen levels were measured in liver and muscle taken from mice allowed to feed ad libitum. n = 5 for each group. All values are presented as average ± SD. ∗p < 0.05. Cell Metabolism 2009 10, 55-62DOI: (10.1016/j.cmet.2009.06.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 Binding of CREB to Select Target Sequences Is Reduced in CRTC2 Knockout Hepatocytes (A–C) ChIP assays were performed on chromatin isolated from the livers of CRTC2−/− (−/−) or control (+/+) mice fasted for 6 or 24 hr using antibodies against CBP (A), p300 (B), or CREB (C). Quantitative PCR was performed to determine enrichment of sequences associated with the PEPCK, G6Pase, and PGC-1α genes. n = 5–9 for each group. (D–E) Schematics of the PEPCK (D) and PGC-1α (E) genes, indicating the location of the unique CREB-binding regions as determined by ChIP-Seq analysis. The distal PEPCK element is located at −5870 bp relative to its transcription start site, while the PGC-1α region is located at +8020 bp within intron 2. The CRE sequences are underlined. Notice that peaks near the respective promoters, where presumptive CRE sequences have been described (arrowheads), are not as pronounced, indicating enhanced CREB occupancy at the sites. All values are presented as average ± SEM. ∗p < 0.05. Cell Metabolism 2009 10, 55-62DOI: (10.1016/j.cmet.2009.06.006) Copyright © 2009 Elsevier Inc. Terms and Conditions